4th Quarter - Report

KNIGHT CAPITOL CONSULTANTS for PERSPECTUM

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues associated with diagnosing and treating the effects of COVID-19 appropriately (no specific legislation). Commission to study COVID-19 (draft Menendez proposal, no bill number yet); NASH Care Act (no bill number yet).

Foreign entity interest: Perspectum, a leading diagnostic company focused on health solutions that can be achieved at scale through a combination of advanced physics and AI, is headquartered in the United Kingdom.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff to Senator Orrin G. Hatch

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Reimbursement of new technologies in Medicare, including the Medicare Coverage of Innovative Technology Program (No specific legislation) and ARPA-H legislation (DeGette/Upton,no bill number yet).

Foreign entity interest: Perspectum, a leading diagnostic company focused on health solutions that can be achieved at scale through a combination of advanced physics and AI, is headquartered in the United Kingdom.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff to Senator Orrin G. Hatch

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Funding for research and clinical trials related to long term studies of COVID-19 at the National Institutes of Health provided in the Consolidated Appropriations Act of 2021 (PL 116-260); Funding for Long-Covid studies in the FY 2022 appropriations bill for HHS (H.R. 4502/no Senate bill yet). Potential funding for long COVID-related research (HR 4502, no Senate number yet).

Foreign entity interest: Perspectum, a leading diagnostic company focused on health solutions that can be achieved at scale through a combination of advanced physics and AI, is headquartered in the United Kingdom.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4502 (117th)

Medical/Disease Research/Clinical Labs MED

Food and Drug Administration regulation of medical devices, including Emergency Use Authorizations for critical products during the COVID-19 crisis.

Foreign entity interest: Perspectum, a leading diagnostic company focused on health solutions that can be achieved at scale through a combination of advanced physics and AI, is headquartered in the United Kingdom.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.